Atraumatic Spinal Needles Market Global Report 2026

The atraumatic spinal needles market size has grown strongly in recent years. It will grow from $0.17 billion in 2025 to $0.18 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increasing number of surgical procedures requiring spinal anesthesia, growing prevalence of neurological disorders requiring lumbar puncture, rising awareness of post-dural puncture headache prevention, expanding healthcare infrastructure, improving access to minimally invasive medical devices.

The atraumatic spinal needles market size is expected to see strong growth in the next few years. It will grow to $0.24 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for safer neuraxial procedures, growing adoption of outpatient surgical services, rising healthcare expenditure in emerging economies, expanding use of spinal anesthesia in elderly patients, increasing emphasis on infection prevention and patient safety. Major trends in the forecast period include increasing adoption of atraumatic spinal needles for spinal anesthesia, growing preference for pencil-point needle designs to reduce post-dural puncture headaches, rising use of minimally invasive lumbar puncture procedures, expanding utilization of disposable sterile spinal needle kits, increasing focus on patient safety during neuraxial procedures.

The increasing volume of spinal anesthesia procedures is anticipated to drive the growth of the atraumatic spinal needles market in the coming years. Spinal anesthesia procedures are surgical and medical interventions in which a local anesthetic is administered into the cerebrospinal fluid within the subarachnoid space using a spinal needle to achieve temporary loss of sensation below the injection site. The rising number of spinal anesthesia procedures is attributed to the growing volume of surgical interventions, increasing elderly population, and higher adoption of minimally invasive anesthesia techniques that offer rapid onset, effective pain management, and quicker postoperative recovery. Spinal needles play a critical role in these procedures by facilitating the accurate and safe delivery of anesthetic agents into the subarachnoid space, ensuring effective anesthesia administration and minimizing procedural risks. For instance, in January 2026, according to the National Institutes of Health (NIH), a US-based government biomedical research agency, a multicenter study involving 102 patients who underwent repeat spinal anesthesia for intrapartum cesarean section found that only 17.6% required conversion due to unsuccessful repeat spinal anesthesia, while 8.8% required general anesthesia. These results demonstrate the continued widespread use and clinical dependence on spinal anesthesia for cesarean deliveries, thereby contributing to sustained demand for spinal needles. Therefore, the increasing volume of spinal anesthesia procedures is contributing to the growth of the atraumatic spinal needles market.

The rising number of surgical procedures is expected to accelerate the growth of the atraumatic spinal needles market in the forecast period. Surgical procedures are medical interventions performed by trained healthcare professionals using specialized instruments and operative methods to diagnose, treat, repair, remove, or reconstruct tissues or organs to enhance a patient’s health outcomes or physical function. The increasing prevalence of chronic conditions, including cardiovascular diseases, cancer, and degenerative musculoskeletal disorders, along with the growing aging population, is leading to a higher number of patients requiring surgical treatments, thereby increasing the overall demand for surgical procedures. Atraumatic spinal needles incorporate a pencil-point tip design that separates instead of cutting dural fibers, helping reduce the occurrence of post-dural puncture headaches and improving patient comfort and recovery after surgical procedures conducted under spinal anesthesia. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery, a US-based professional organization, the total number of surgical and non-surgical procedures increased by 3.4% in 2023, reaching 34.9 million. Therefore, the rising number of surgical procedures is driving the growth of the atraumatic spinal needles market.

Key companies operating in the atraumatic spinal needles market are focusing on developing advanced spinal needle portfolios with enhanced ergonomic designs, improved cerebrospinal fluid (CSF) visualization, and features that improve procedural precision and patient outcomes. Spinal needle portfolios are collections of spinal needle products offering different gauges, lengths, and configurations to meet diverse clinical requirements. For example, in March 2025, B. Braun, a Germany-based medical technology company, introduced its Spinal NX portfolio, featuring Pencan, Atraucan, and Spinocan spinal needles for spinal anesthesia and diagnostic procedures. The portfolio includes the Pencan atraumatic pencil-point needle, designed to minimize intrathecal penetration depth and reduce the risk of post-dural puncture headache (PDPH), along with an ergonomic hub for enhanced needle control, a CSFID system for improved cerebrospinal fluid flashback visualization, and Tritan hub material to improve durability and clinician handling.

Major companies operating in the atraumatic spinal needles market report are B. Braun Melsungen AG, BD (Becton Dickinson and Company), Teleflex Incorporated, PAJUNK GmbH, Vygon SAS, Nipro Corporation, Medikit Co. Ltd., Nanchang Kindly Meditech Co. Ltd., Vogt Medical GmbH, Zhejiang Runqiang Medical Instruments Co. Ltd., Zoray Precision Technology, Hakko Medical Co. Ltd., Unisis Corp., Dr. Japan Co. Ltd., Spectra Medical Devices LLC, Egemen International, GEM S.r.l., Suretech Medical Inc.

North America was the dominant region in the atraumatic spinal needles market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the atraumatic spinal needles market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the atraumatic spinal needles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.